Despite its minor flaws, lack of logic, and lecture-style moral narrative, Vettaiyan should be enjoyed in a theatre amid Rajini fans and their wolf whistles, endorses Divya Nair.
'The combination of star power, compelling storytelling, and action-packed drama promises to set the box office ablaze and kickstart the new quarter on a spectacular high note.'
Vicky Vidya Ka Woh Wala Video managed to do better than Jigra as it is more massy in its treatment and presentation.
Six Telugu film actors, including Rana Daggubati, Prakash Raj, and Vijay Deverkonda, along with 19 social media influencers have been booked for allegedly promoting betting apps. A businessman filed a complaint alleging that the celebrities and influencers were promoting these apps on social media through pop-up ads and other means. The police registered a case under relevant sections of the BNS, Gaming Act, and IT Act based on the complaint and are planning to issue notices to those named in the FIR.
Dushara Vijayan's seductive eyes make her appear exceptional in every aspect!
With the eagerly awaited Pushpa 2: The Rule set for release in December, there's a chance the industry could match, if not surpass, the collections of 2023.
Rajinikanth, who had been admitted to Chennai's Apollo Hospital on September 20 after complaining of ill health, was discharged on Thursday night.
Kareena's cop, Rajni's supercop and Samantha's spy, it's a star-studded week on OTT this time. Sukanya Verma lists your options on OTT this week.
Bollywood seems to have ignored the month of September, with only two Hindi releases coming up in theatres. But cine-goers need not worry, as Hollywood and south cinema makes up for it.
Ananya takes CTRL... Shraddha cheers for her BFF... Manju says hello to India's megastars...
Laid-back and relaxed doesn't seem to be a part of this actor's style vocabulary.
Aishwarya and Soundarya visited the temple with their family.
Will these 2024 releases -- bookended by Rajinikanth no less -- make a dhamaka at the box office?
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances